Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284397 · ClinicalTrials.gov registry record · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
A Early Phase 1 study of Aging, sponsored by Penn State University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT04284397: Recruiting Early Phase 1 study of Aging, sponsored by Penn State University.
NCT04284397 is a Early Phase 1 study of Aging that is actively recruiting participants, run by Penn State University. The registered enrollment target is 190 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04284397, a Early Phase 1 study of Aging, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates critical environmental limits (temperature and humidity) above which older adults are unable to effectively thermoregulate. Participants will exercise in a series of different environmental conditions to identify combinations of temperature and humidity above which age-related physiological changes cause uncompensable heat stress, resulting in increased risk of heat illness.
Primary Outcome
Core temperature will be measured throughout exercise. The point at which heat stress becomes uncompensable will be determined for each environmental and exercise condition by assessing the combination of temperature and humidity at which core temperature begins to rise.
Conditions Studied
Interventions
- OTHER Control
- DRUG Low dose ASA
Study Locations (1)
Pennsylvania
- Noll Laboratory - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2027-02-27 |
| Phase | Early Phase 1 |
What NCT04284397 shows while recruiting
NCT04284397 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT04284397 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04284397 about?
NCT04284397 is a clinical study titled "Identification of Critical Thermal Environments for Aged Adults". This study evaluates critical environmental limits (temperature and humidity) above which older adults are unable to effectively thermoregulate. Participants will exercise in a series of different environmental conditions to identify combinations of temperature and humidity above which age-related p...
What is the current status of trial NCT04284397?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 190 participants. The study started on 2020-12-30. Estimated completion is 2027-02-27.
What conditions does trial NCT04284397 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT04284397?
The interventions under investigation include: Control (OTHER), Low dose ASA (DRUG).
Who is sponsoring clinical trial NCT04284397?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04284397 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04284397's enrollment target sits among peer trials
190 53rd of 262 higher than 210 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gene Expression Changes In Young and Geriatric Skin
RECRUITING · Early Phase 1
-
Examining the Effects of Theta Burst TMS on Brain Connectivity and Balance Ability in Older Adults With Balance Problems
RECRUITING · Early Phase 1
-
Transient Receptor Potential Channels
RECRUITING · Early Phase 1
-
Early Neurovascular Adaptations in Aging Women
RECRUITING · Early Phase 1
-
Heat, Microvascular Function and Aging
RECRUITING · Early Phase 1
-
Angiotensin-(1-7) Cardiovascular Effects in Aging
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04554914 · 190 participants · Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI